p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This is multicenter, open-label, randomized, active-controled, phase IV study of local direct intra-tumor injection of rAd-p53 monotherapy, with concurrent chemotherapy , with concurrent radiotherapy, or combination with surgery for treatment of head and neck malignant tumors in advanced stage .
Epistemonikos ID: b5c70e52d69f89f4191004d2c9016e9021101589
First added on: May 05, 2024